Baxter Healthcare Corporation is recalling 472 vials of Doxil (doxorubicin hydrochloride liposome injection) because the medication was exposed to temperatures higher than the labeled storage conditions during transportation. This lot was released for distribution by mistake after the storage deviation occurred. No injuries or adverse events have been reported to date regarding this recall.
Exposure to temperatures outside of the required storage range can compromise the stability and effectiveness of the medication. This may potentially reduce the therapeutic benefits of the drug for patients undergoing treatment.
Quantity: 472 vials
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.